Astek Diagnostics’ Courtney Cavin Honored by Forbes 30 Under 30 — Spotlight on Next‑Gen Healthcare Innovation
Baltimore, MD — December 9, 2025
Astek Diagnostics, a pioneer in rapid precision diagnostics, is proud to announce that Courtney Cavin, a rising leader at the company, has been named to Forbes’ 30 Under 30 list for the Class of 2026. This is a recognition reserved for the most promising entrepreneurs, innovators, and change‑makers under the age of 30.
This honor underscores both Courtney’s individual vision and the growing impact of Astek Diagnostics’ mission to transform infection diagnostics. Forbes’ 30 Under 30 list annually recognizes 600 leaders across 20 industries, spotlighting innovators whose work is shaping the future of business, technology, healthcare, and social impact.
Courtney Cavin: A Young Leader Accelerating Diagnostic Innovation
At Astek Diagnostics, Courtney Cavin has played a key role in advancing the company’s flagship solution, the Jiddu™ Platform, a rapid diagnostic system that can detect bacterial infections and determine antibiotic susceptibility within one hour. Under Courtney’s leadership and commitment to healthcare innovation, the company continues to push forward rapid, precision diagnostics for patient populations with urgent unmet needs, including individuals with spinal cord injury and complex care needs.
In reflecting on the honor, Courtney Cavin said:
“Being part of the Class of 2026, Forbes 30 under 30 in Healthcare is an honor. I have always viewed the list as a world changing group I aspire to be like.”
She added, “I’ve always wanted to make an impact in healthcare, and building something from the ground up at Astek Diagnostics has allowed me to see all the ways our system and technologies can do better.”
What This Means for Astek Diagnostics:
Being recognized by Forbes not only highlights Courtney’s achievements but also reflects the potential of Astek Diagnostics to lead the next generation of diagnostic innovation. As part of the Forbes 30 Under 30 cohort, Courtney and Astek gain enhanced visibility in the global healthcare and startup community and amplifying their ability to forge partnerships, attract talent, and accelerate the development and deployment of rapid diagnostic solutions.
Astek remains committed to delivering on its mission: providing clinicians with faster, more accurate infection diagnostics that can guide targeted antibiotic therapy, reduce delays in care, and ultimately improve patient outcomes. The inclusion of Courtney in Forbes 30 Under 30 reinforces confidence in that mission and the team driving it.
About Astek Diagnostics
Astek Diagnostics is a medical technology company developing advanced diagnostic tools to deliver actionable infection insights within an hour. Its patented Jiddu™ Platform enables clinicians to rapidly confirm bacterial infections and determine antibiotic susceptibility at the point of care. Thus, supporting precise treatment decisions, reducing unnecessary antibiotic use, and improving patient outcomes. Astek is committed to transforming the speed and accuracy of infection diagnostics across healthcare settings.